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Background: Recent epidemiological evidence suggests that modifying lifestyle by increasing physical activity could
be a non-pharmacological approach to improving symptoms and slowing disease progression in Alzheimer’s disease
and other tauopathies. Previous studies have shown that exercise reduces tau hyperphosphorylation, however, it is not
known whether exercise reduces the accumulation of soluble or insoluble tau aggregates and neurofibrillary tangles,
which are both neuropathological hallmarks of neurodegenerative tauopathy. In this study, 7-month old P301S tau
transgenic mice were subjected to 12-weeks of forced treadmill exercise and evaluated for effects on motor function
and tau pathology at 10 months of age.
Results: Exercise improved general locomotor and exploratory activity and resulted in significant reductions in full-
length and hyperphosphorylated tau in the spinal cord and hippocampus as well as a reduction in sarkosyl-insoluble
AT8-tau in the spinal cord. Exercise did not attenuate significant neuron loss in the hippocampus or cortex. Key proteins
involved in autophagy—microtubule-associated protein 1A/1B light chain 3 and p62/sequestosome 1 —were also
measured to assess whether autophagy is implicated in the exercised-induced reduction of aggregated tau protein.
There were no significant effects of forced treadmill exercise on autophagy protein levels in P301S mice.
Conclusions: Our results suggest that forced treadmill exercise differently affects the brain and spinal cord of aged
P301S tau mice, with greater benefits observed in the spinal cord versus the brain. Our work adds to the growing body
of evidence that exercise is beneficial in tauopathy, however these benefits may be more limited at later stages of
disease.
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More than 35 million people worldwide are affected by
dementia [1], with the leading cause being Alzheimer’s
disease (AD), primarily affecting those aged 65 years or
older [2]. Central nervous system (CNS) accumulation of
hyperphosphorylated tau and amyloid-beta proteins are
pathological hallmarks of AD, whereas tau accumulation
also occurs in other tauopathies such as frontotemporal
dementia (FTD), Pick’s disease (PiD), progressive supra-
nuclear palsy (PSP) and corticobasal degeneration (CBD).
These diseases are all characterized by the intraneuro-
nal or glial accumulation of neurofibrillary tangles (NFTs),* Correspondence: jeriksen@central.uh.edu
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article, unless otherwise stated.which are comprised of hyperphosphorylated and aggre-
gated tau protein [3-5]. There are no approved treatments
for diseases with only tau inclusions [6], whereas the cur-
rently approved drugs for AD temporarily relieve symp-
toms without altering disease progression [7].
Given the prevalence of these disorders, there is sig-
nificant scientific and clinical interest in developing new
approaches that can be used to prevent disease onset
and to attenuate disease progression. Clinical studies
suggest that being physically active later in life may be
neuroprotective by preserving cognition [8-11], increas-
ing neurotropic factors [12,13], and maintaining the
structural integrity of the brain [14,15]. Additionally, the
neuroprotective benefit of physical exercise has been
demonstrated in patients as well as in animal models ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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[16] and measures of functional independence [17], in
addition to improvements in cognitive function [18],
have been reported in AD patients subjected to aerobic
and/or anaerobic forms of exercise. In animal models of
AD, exercise has been reported to have a range of bene-
ficial effects, such as a reduction in the build-up of amyl-
oid beta (Aβ) plaques, soluble and fibrillar Aβ peptides
[19-21], and improvements in cognitive [19,22-24] as
well as non-cognitive [25] behaviors. In addition to effects
on Aβ pathology, there is some evidence of exercise-
induced benefits in tauopathy. Steffen and colleagues
reported a case of improved motor function and an at-
tenuated rate of brain volume loss in a patient with
CBD and PSP after 2.5 and 10 years of exercise [26,27].
In support of the clinical data, there is also evidence
that exercise can alter soluble forms of tau phosphoryl-
ation and positively affect behavioral deficits in trans-
genic mouse models [28,29].
While much research has been devoted to understand-
ing the mechanisms by which physical activity can re-
duce or prevent the pathological consequences of toxic
Aβ accumulation in AD [19,22,23,30-36], the impact of
exercise on the neurodegenerative process in tauopathy
is not as well understood. It is known that forced tread-
mill exercise can decrease tau hyperphosphorylation in
NSE/htau23 mice [28], however this model does not ap-
pear to develop neurofibrillary tangles or neurodegener-
ation [37]. There is also evidence that voluntary wheel
running can reduce tau hyperphosphorylation in THY-
Tau22 mice [29], but it is not known whether exercise
can affect both soluble and sarkosyl-insoluble (or aggre-
gated) forms of tau, which are also pathological hallmarks
of tauopathies [4]. Reductions in tau could potentially
occur by a number of mechanisms, but there is evidence
that autophagy can be induced in the brain by treadmill
exercise [38], and recent reports indicate that pharmaco-
logical activation of autophagy via trehalose [39] or rapa-
mycin [40] reduces soluble and insoluble tau aggregation
in P301S mice. Based on these reports, we hypothesized
that the induction of autophagy by exercise could play a
role in reducing tau pathology.
In this study, we assessed whether long-term endurance
treadmill exercise introduced after the onset of neurode-
generative tauopathy could improve general locomotor
function and slow the development of tau neuropathology,
possibly through inducing autophagy. Although there is
evidence that short-term exercise is beneficial by increas-
ing neurotrophic factors, cell proliferation and synaptic
protein levels in the non-diseased rodent brain [41-44],
long-term exercise has also been reported to produce
similar benefits [45]. However, the effects of either short-
or long-term exercise in diseased rodent models are more
complex. Previous reports indicate that the benefits ofexercise in AD mouse models depend on the duration and
type of exercise protocol. For example, short-term, volun-
tary (wheel-running) exercise did not have a significant
impact on Aβ pathology after 3 to 4 weeks [46-48] or
6 weeks [49] of training. Conversely, 3-, 5- and 6-months
of voluntary exercise reduced pathology (tau or Aβ) in
THY-Tau22 [29], TgCRND8 [19] and 3xTg-AD [50] mice,
respectively. Forced treadmill exercise is beneficial after
short and long periods of training, as 4 weeks of exer-
cise reduced Aβ pathology in APP/PS1 mice [47], and
3 months of exercise reduced Aβ or tau pathology in
NSE/PS2 [35] and NSE/htau23 [28,51] mice. Based on
this prior evidence, for the present study we chose to
introduce P301S tau transgenic mice—which overex-
press the P301S-mutant human tau associated with
clinical cases of neurodegenerative tauopathy [52]—to a
12-week forced treadmill exercise regimen that has
been reported to benefit a Parkinsonian mouse model
of neurodegeneration [53,54].Results
Exercise increases general locomotor and exploratory
behavior in P301S mice
To assess whether introduction of treadmill exercise could
affect animal locomotor activity and exploratory behavior,
P301S tau transgenic mice and matching non-transgenic
counterparts were tested in the open field. Exercise
training resulted in enhanced total exploratory activity
in P301S mice. Two-way analysis of variance (ANOVA)
revealed a main effect of exercise, [F(1, 32) = 8.1829,
p < 0.01]. Newman-Keuls post-hoc indicated that the trans-
genic exercised (Tg-EX) mice had significantly higher total
activity versus the transgenic sedentary (Tg-SED) mice
(p < 0.01; Figure 1A). We also observed a significant main
effect of exercise in total distance traveled, [F(1,32) =
5.6585, p < 0.05], where Tg-EX mice traveled more than
Tg-SED mice (p < 0.05; Figure 1B), and ambulatory activity
[F(1,32) = 7.9197, p < 0.01], where Tg-EX mice dis-
played increased ambulation versus Tg-SED mice (p <
0.05; Figure 1C). Exercise-enhanced locomotor behav-
ior in Tg-EX mice was not attributed to either rearing
activity, [F(1,32) = 0.2072, p = 0.652] (Figure 1D) or stereo-
typic activity, [F(1,32) = 0.0573, p = 0.812] (Figure 1E).
Additionally, increased locomotor and exploratory ac-
tivity of Tg-Ex mice was not due to decreased anxiety-
like behavior, as all groups spent a similar amount of
time in the center of the testing chamber, [F(1,32) =
0.1514, p = 0.700] (Figure 1F). There were no significant
differences in locomotor or exploratory performance
between the non-transgenic exercised (NTg-EX) and
non-transgenic sedentary (NTg-SED) groups in total activ-
ity (p = 0.446; Figure 1A), total distance traveled (p =






























































































































Figure 1 Open-field locomotor performance enhanced in P301S transgenic mice after 12-weeks of forced treadmill exercise. Transgenic
exercised mice (Tg-EX) showed locomotor improvements in total activity (A), total distance traveled (B), and ambulatory activity (C) when compared
to transgenic sedentary mice (Tg-SED). No significant changes were observed in rearing (D), stereotypic activity (E) and time spent in the center (F).
[NTg-SED (n = 10), NTg-EX (n = 8), Tg-SED (n = 6), Tg-EX (n = 8)]. *p < 0.05 = Tg-SED vs Tg-EX. A two-way ANOVA with the Newman-Keuls post-hoc was
used to detect statistically significant differences.
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tau immunofluorescence in P301S mice
We used a Student’s t-test to compare Tg-SED and Tg-EX
groups and observed a significant reduction in total
(TAU5) and phospho-tau immunofluorescence in the
spinal cord (p < 0.05; Figures 2 and 3A) and hippocampus
(p < 0.05; Figures 2 and 3C) of Tg-EX mice (Figure 3A,C)
after exercise. Tau phosphorylated at sites Ser202 and
Thr205 (AT8) was also significantly reduced in the
spinal cord (p < 0.05; Figure 3A) and hippocampus (p <
0.05; Figure 3C), in the Tg-EX mice. Additionally, a signifi-
cant reduction in tau phosphorylated at sites Thr212/
Ser214 (AT100) and Thr231 (AT180) was observed in the
spinal cord (p < 0.05; Figure 3A), while a reduction in
AT180 in the hippocampus almost reached statistical sig-
nificance (p = 0.058; Figure 3C). No significant changes in
total and phosphorylated tau were observed in the cortex
(Figures 2 and 3B). When the CA1 and CA3 subregionswere separately measured, exercise appeared to signifi-
cantly reduce TAU5 immunofluorescence in the CA1 ver-
sus the CA3 of the hippocampus. We also observed
marginal reductions in AT180 in the both sub regions
after exercise (Figure 3D).
Exercise has differential effects on soluble and insoluble
tau in the spinal cord and brain of P301S mice
In order to assess whether exercise could affect the
levels of pathological tau, we performed sequential RIPA
and sarkosyl-extractions to quantify levels of soluble and
insoluble tau protein, respectively [55]. A Student’s t-test
was used to analyze differences between Tg-SED and Tg-
EX groups. We observed marginal reductions in total
soluble tau protein in the spinal cord (45% decrease),
cortex (25% decrease), and hippocampus (27% decrease)
in Tg-EX versus transgenic sedentary (Tg-SED) mice.






































Figure 2 Total and phosphorylated tau immunofluorescence is reduced in the spinal cord and brain of P301S transgenic mice after
12-weeks of forced treadmill exercise. Representative images of total (TAU5, A) and phosphorylated tau (AT8, A; AT100 and AT180, B)
immunofluorescence in the spinal cord (dorsal horn), cortex (layers I-II), and hippocampus. For spinal cord and cortex images, scale bars represent
100 μm. For hippocampus images, scale bar represents 200 μm. Green = TAU5; red = AT8, AT100, or AT180; blue = DAPI.
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cortex (41% decrease) but not in the hippocampus (TAU5:
Figure 4B, D and F) of Tg-EX versus Tg-SED mice. Soluble
AT8-tau was reduced in Tg-EX versus Tg-SED mice in the
spinal cord (35% decrease) and cortex (40% decrease), but
not the hippocampus (Figure 4A, B and C); however, a sig-
nificant reduction in insoluble AT8-tau was observed inthe spinal cord (p < 0.05; Figure 4B). No significant reduc-
tions in insoluble AT8-tau were observed in the cortex or
hippocampus after exercise (Figure 4D,F). Exercise did not
appear to significantly influence the levels of soluble and
insoluble AT100-tau in the spinal cord of Tg-EX com-
pared to Tg-SED mice (Figure 4A and B). In the cortex,








































































































Figure 3 Total and phosphorylated tau immunofluorescence is reduced in the spinal cord and brain of P301S transgenic mice after
12-weeks of forced treadmill exercise. A) Total (TAU5) and phosphorylated (AT8, AT100, and AT180) tau were significantly reduced in the spinal
cord of the exercised P301S mice. B) No statistically significant changes in total and phosphorylated tau immunofluorescence were observed in in the
cortex exercised versus sedentary transgenic mice. C) Significant reductions in TAU5 and AT8 were observed in the hippocampus of exercised P301S
mice. D) Exercise significantly affected TAU5 immunofluorescence in the CA1 versus the CA3 of the hippocampus. [n = 6-8 per group]; (*) denotes a
significant difference (p < 0.05). A Student’s t-test was used to detect statistically significant differences.
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Figure 4 RIPA-soluble and sarkosyl-insoluble tau levels in the spinal cord, cortex, and hippocampus of P301S transgenic mice. RIPA-soluble
total (TAU5) and phosphorylated (AT8, AT100, AT180) protein quantification via Western blot analysis of the A) spinal cord, C) cortex, and E)
hippocampus revealed no significant reductions in exercised versus sedentary P301S mice. Sarkysol-insoluble total and phosphorylated Western blot
analysis of the D) cortex and F) hippocampus did not reveal significant reductions in exercised versus sedentary P301S mice, however the B) spinal
cord revealed a significant reduction in AT8-tau. [n = 6-8 per group] (*) denotes a significant difference (p < 0.05). Student’s t-test was used to detect
statistically significant differences.
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cortex of Tg-EX mice (Figure 4C,D). No significant reduc-
tions in soluble or insoluble AT100-tau were observed in
the hippocampus (Figure 4E,F). We also did not observe
any reductions in soluble or insoluble AT180-tau in the
spinal cord, cortex and hippocampus of Tg-EX versus Tg-
SED mice (Figure 4A-F). Dot blot analysis revealed that
exercise did not affect the levels of tau oligomers in anyregion; mice from the Tg-EX group displayed similar levels
of oligomeric tau in the spinal cord, cortex and hippocam-
pus (Figure 5A,C).
Exercise does not impact neuronal cell number in the
spinal cord or brain of P301S mice
Quantification of motor neurons in the spinal cord re-








































Figure 5 Soluble tau oligomers are present in the spinal cord and brain of P301S mice. A) Dot blot analysis indicates similar levels of
oligomeric tau in the spinal cord, cortex, and hippocampus. B) Representative images of immunofluorescence of the spinal cord, cortex and
hippocampus revealed similar T22 staining in sedentary versus exercised mice. Scale bar represents 50 μM for all images. C) Representative dot
blots of T22 in the spinal cord, cortex, and hippocampus. [N = 4 per group]. Blue, DAPI; green, TAU5; red, T22. A Student’s t-test was used to detect
statistically significant differences.
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effect of genotype, [F(1,28) = 0.2212, p = 0.642] or exer-
cise, [F(1,28) = 0.8274, p = 0.371] (Figure 6A). Cortical
neurodegeneration was observed in P301S mice, with a
main effect of genotype, [F(1, 27) = 27.8664, p < 0.01].
Tukey’s HSD post hoc revealed that the Tg-SED group
had less NeuN-positive cells than the NTg-SED group
(p < 0.05; Figure 6B). Similarly, the Tg-EX group had less
NeuN-positive cells than the NTg-EX group (p < 0.01;
Figure 6B). P301S transgenic mice displayed neurode-
generation in the cornus ammonis (CA) 3 of the hippo-
campus, with a main effect of genotype, [F(1, 24) =
41.5653, p < 0.01]. Tukey’s HSD post hoc revealed that
Tg-SED mice had significantly fewer NeuN-positive
cells than NTg-SED mice (p < 0.05; Figure 6D) and the
Tg-EX mice had fewer NeuN-positive cells than the
NTg-EX mice (p < 0.01; Figure 6D). Neurodegeneration
was also observed in the CA1 of the hippocampus of
P301S mice [F(1, 27) = 57.0844, p < 0.01] with both Tg-
SED and Tg-EX mice displaying significantly fewer NeuN-
positive cells than their NTg counter parts (p < 0.01;
Figure 6C).
Exercise and autophagy-related proteins in P301S mice
We did not observe any significant effects of exercise on
protein levels of microtubule-associated protein 1A/1B
light chain 3-II (LC3-II) and p62/sequestosome 1 (p62/SQSTM1) of the NTg versus Tg groups. A Student’s t-
test was used to compare differences between groups. In
the spinal cord, protein levels of LC3-II (p = 0.2380)
and p62 (p = 0.1839) were not significantly different in
NTg-SED versus NTg-EX mice (Figure 7). Similarly, no
differences were observed in the cortex (LC3-II: p =
0.7610; p62: p = 0.1607) and hippocampus (LC3-II: p =
0.4773; p62: p = 0.6878) of NTg-SED versus NTg-EX
mice (Figure 7). We also did not observe any significant
differences in the spinal cord (LC3-II: p = 0.2040; p62:
p = 0.16901), cortex (LC3-II: p = 0.7037; p62: p = 0.5223)
and hippocampus (LC3-II: p = 0.7632; p62: p = 0.9497) of
Tg-SED versus Tg-EX mice (Figure 7). While not statis-
tically significant, lower levels of both microtubule-
associated protein 1A/1B light chain 3-II (LC3-II) and
p62/sequestosome 1 (p62/SQSTM1) were observed after
exercise in non-transgenic mice. We did not observe
strong LC3-I bands in the cortex and hippocampus
(Figure 7A), which could be due to the greater sensitiv-
ity of the anti-LC3 antibody to LC3-II over LC3-I in
some cases [56]. When probing for p62/SQSTM1 in
the spinal cord, we observed lower levels in Tg-EX mice
versus Tg-SED mice and the presence of a stronger
37 kDa band in the spinal cord, cortex, and hippocampus
of transgenic versus non-transgenic mice (Figure 7D). The
37 kDa band is known to be a product of caspase cleavage




Figure 6 (See legend on next page.)
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Figure 6 Forced treadmill exercise does not affect neuronal cell counts in the spinal cord and brain. A) Spinal cord motor neuron counts
were not significantly different across all groups. B) Transgenic mice displayed significant neurodegeneration in the cortex compared to non-transgenic
controls. C) Transgenic mice displayed significant neurodegeneration in the CA3 of the hippocampus compared to non-transgenic controls.
D) Transgenic mice displayed significant neurodegeneration in the CA1 of the hippocampus compared to non-transgenic controls. E) Representative
images of the spinal cord and cortex. Scale bars represent 50 μm for spinal cord and 100 μm for the cortex. F) Representative images of the CA1 and
CA3 subregions of the hippocampus. Scale bar represents 25 μm. [NTg-SED (n = 6), NTg-EX (n = 8), Tg-SED (n = 6), Tg-EX (n = 8)]; (*) denotes a
significant difference (p < 0.05). A two-way ANOVA with the Tukey’s HSD post-hoc was used to detect statistically significant differences.
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transgenic mice, whereas these bands were not present in
the non-transgenic mice (Figure 7D). Additionally, we ob-
served accumulation of LC3-II and p62/SQSTM1 in the
sarkosyl-insoluble fraction of the spinal cord, cortex and
hippocampus of P301S mice (Figure 7E).
Discussion
Pathological tau and/or Aβ accumulation occurs in Alz-
heimer’s disease and other tauopathies. There are numer-
ous reports that have focused on the exercise-induced
reductions of Aβ pathology and behavioral impairments in
animal models of Alzheimer’s disease [19-25,32,34]. It has
been reported that exercise can also reduce soluble
hyperphosphorylated tau in mouse models of tauopathy
[28,29]. In this report, we investigated whether long-
term (12 weeks) forced treadmill exercise could attenuate
or prevent the progression of tauopathy in mice that over-
express human P301S-mutated tau. The P301S mutation
is associated with familial forms of FTD [3,59,60], and is
known to cause hyperphosphorylation, aggregation and
filament formation of tau [61], which decreases the affinity
of tau for microtubules and leads to subsequent neurode-
generation and the development of NFTs. P301S tau
transgenic mice develop extensive tau pathology in the
spinal cord at 6 months of age [39,62] accompanied by
neurogenic muscle atrophy [52], which results in a pro-
gressive decline in locomotor function. While our P301S
mice had slightly lower activity in the open field, we did
not observe a profound deficit in general locomotor and
exploratory activity in our 10-month old P301S mice
compared to the non-transgenic mice, potentially due
to phenotypic drift that has been previously reported in
this mouse line [63-65].
We observed significant tau pathology in our 10-month
old mice and forced exercise training significantly en-
hanced locomotor and exploratory activity in Tg-EX ver-
sus Tg-SED mice. Our observations are in accordance
with recent clinical evidence [26,27] showing that a pa-
tient diagnosed with CBD and PSP that participated in a
regular exercise program (including treadmill training) for
10 years displayed reduced fall frequency, as well as im-
proved balance and ambulation after exercise training
[27]. The enhancement of locomotor ability we observed
could be attributable to a variety of factors. We observedsignificant reductions in tau hyperphosphorylation and ag-
gregation in the spinal cord, an indication that the pro-
gression of tau pathology was attenuated by exercise.
Hyperphosphorylation and aggregation of tau are associ-
ated with synapse loss [52] and altered synaptic function
[66] in P301S mice, so it is possible that treadmill exercise
prevented these alterations in the spinal cord, restoring
adequate neurotransmission at the neuromuscular junc-
tion. Treadmill exercise elevates the expression of synap-
tophysin and synapsin 1 [67-73], as well as post-synaptic
density protein-95 [68,74,75], supporting the notion that
exercise enhances synaptic neurotransmission. A reduc-
tion in tau pathology via exercise could result in an in-
crease in expression of synaptic proteins, or this increase
could occur directly via forced exercise, resulting in en-
hanced synaptic transmission in the spinal cord and im-
proved locomotor function.
Pre-neurofibrillary tangles are comprised in part, by
pThr231 tau, while extracellular and intracellular neuro-
fibrillary tangles (comprised of mostly filamentous tau)
are stained with antibodies that recognize phosphoryl-
ation at sites Ser202/Thr205 (AT8) and Thr212/Ser214
(AT100) in Alzheimer’s disease [76]. In our study, we
observed reduced total and hyperphosphorylated tau in
the lumbar spinal cord and hippocampus, showing a sig-
nificant reduction of phosphorylated tau Ser202/Thr205
(AT8) in the spinal cord and hippocampus, and Thr231
(AT180) and Thr212/Ser214 (AT100) in the spinal cords
of Tg-EX mice. These findings indicate that forced tread-
mill exercise attenuates the progression of neurofibrillary
tangle formation in the spinal cord and reduces filament-
ous tau in the hippocampus of P301S mice. Our data are
consistent with the results published by Leem and col-
leagues [28], who reported a reduction in AT8-positive
immunoreactivity in the hippocampus after forced tread-
mill exercise in Tg-NSE/htau23 mice. However, our re-
sults are in contrast to that of previous studies using other
mouse models of tauopathy, where a reduction in AT100
[29] and not AT8-positive immunoreactivity [29,77,78]
was observed in the hippocampus after voluntary wheel
running exercise. The differences in experimental out-
comes could be attributed to different choices of exercise
modality [79], where forced treadmill exercise maybe
more beneficial in tauopathy versus voluntary exercise.
Additionally, different choice of experimental mouse
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Figure 7 (See legend on next page.)
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Figure 7 LC3-II and p62/SQSTM1 Western blot analysis. A) There were no significant effects of exercise on LC3-II levels in P301S or non-transgenic
mice in the spinal cord, cortex, and hippocampus. [N = 3-4 per group] B) Representative western blots of LC3-II. C) There were no significant effects of
exercise on p62/SQSTM1 levels in P301S or non-transgenic mice in the spinal cord, cortex, and hippocampus. Intense 37, 25, and 20 kDa bands were
observed in P301S mice, an indication of proteolytic cleavage. [N = 3-4 per group] D) Representative western blots of p62/SQSTM1. E) Representative
western blots of sarkosyl-insoluble LC3-II and p62/SQSTM1 in the hippocampus, cortex, and spinal cord.
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tioned reports could also be a source of the discrep-
ancy in results.
Despite evidence that exercise can reduce tau hyperpho-
sphorylation in mice [28,29], it is not known whether
forced treadmill exercise can reduce insoluble tau accu-
mulation, which is a pathological characteristic of tauo-
pathies [4]. To address this question, we analyzed
RIPA-soluble and sarkosyl-insoluble forms of tau pro-
tein in the spinal cord and brain of P301S mice. Sarkosyl
protein extractions are routinely used to isolate aggregated
paired helical filaments of tau, which are the primary con-
stituents neurofibrillary tangles [80]. While we observed
marginal reductions in total tau for RIPA-soluble and
sarkosyl-insoluble tau pools in the spinal cord, there was a
significant reduction in sarkysol-insoluble AT8-tau, sug-
gesting that forced treadmill exercise reduces filamentous
tau accumulation. We observed only marginal reductions
in soluble or insoluble tau protein in the hippocampus
and cortex. These observations are similar to our histo-
logical data, where no significant changes in total or
hyperphosphorylated tau were observed in the cortex as
well as in AT100 and AT180 in the hippocampus. In
addition to filamentous tau, we also analyzed the levels of
soluble tau oligomers, which are thought to be toxic par-
ticipants in neurodegenerative tauopathies [81,82]. We
found that P301S tau mice express soluble oligomeric tau;
however, exercise did not appear to significantly affect
oligomeric tau levels in the brain and spinal cord.
Our results suggest that forced treadmill exercise re-
duces total and phosphorylated insoluble tau in the spinal
cord, but only moderate changes occur in the brain. In ac-
cordance with these results, we observed a significant de-
gree of cell loss in the hippocampus and cortex that was
not alleviated by our exercise regimen. In the hippocam-
pus, the CA1 and CA3 regions of P301S mice displayed
neurodegeneration, which is consistent with previous re-
ports in this mouse model [52,77,83]. Both hippocampal
regions have extensive connections with the entorhinal
cortex (EC) [84,85], where significant tau pathology and
cell loss is also observed [52]. Significant neurodegenera-
tion in the CA regions could result from synaptic propa-
gation of tau pathology from the EC [86,87] and/or
degeneration of EC afferents [88,89]. Since the dentate
gyrus (DG) also relies on its connections with the EC
[84,85], it is plausible that tau propagation from the DG to
the CA3 (and the CA1 via the Schaffer collaterals), ordeafferentation could also impact the neurodegenerative
process in CA hippocampal regions.
Given that we did not see significant reductions in hip-
pocampal and cortical soluble or insoluble tau in Tg-EX
mice, neurodegenerative tau pathology in the hippocam-
pus and cortex may have progressed to a stage that could
not be mitigated with 12 weeks of forced treadmill exer-
cise. Previous reports have suggested that forced treadmill
exercise may not reverse or prevent some diseases [90,91]
and in some cases can exacerbate disease progression
[92,93] possibly because of increased stress associated with
the treadmill protocol. However, our exercise regimen did
not appear to worsen tau pathology in the brains of P301S
mice.
Neurodegenerative diseases are characterized by the
accumulation of aggregated proteins, an indication that
there is either increased production or inefficient elimin-
ation of dysfunctional or misfolded proteins that results in
perturbed proteostasis. Both autophagy and the ubiquitin-
proteosome system have been implicated in abnormal
protein accumulation associated with neurodegenerative
processes [94,95]. Therefore, our final aim was to investi-
gate whether autophagy is a possible mechanism by which
tau pathology was mitigated by forced treadmill exercise.
Autophagy activation is characterized, in part, by in-
creased production of LC3-II and increased degradation
of p62/SQSTM1[38,96] relative to baseline levels. We ob-
served that P301S and non-transgenic mice introduced to
forced treadmill exercise did not have significantly in-
creased levels of LC3-II in the spinal cord and brain when
compared to their sedentary counterparts. The levels of
p62/SQSTM1 were marginally reduced after exercise in
the spinal cords of both non-transgenic and P301S mice,
while no changes were observed in the hippocampus and
cortex; therefore, the reduced levels of p62/SQSTM1 we
observed in the spinal cord of NTg-EX and Tg-EX mice
could be an indication of autophagy induction. We ob-
served significant reductions of insoluble AT8-tau in the
spinal cord, which could be a result of degradation of tau
aggregates by exercise-induced autophagy. In support of
this notion, pharmacological activation of autophagy via
rapamycin [40] and trehalose [39,97] reduces insoluble
AT8-tau in P301S mice. In addition to aggregated tau,
autophagy is also known to promote the degradation of
several aggregated proteins associated with neurodegener-
ative disease, including Aβ [98], huntington [99,100], and
alpha-synuclein [100,101]. However, we did not observe
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SQSTM1 in the brain.
In this study, P301S mice displayed multiple lower
molecular weight p62/SQSTM1 bands (37, 25 and 20 kDa)
in the spinal cord. This observation is consistent with in-
creased caspase or calpain cleavage [57,58], which suggests
that the P301S mutation could result in a selective disrup-
tion of the autophagic processes, potentially attributable to
the loss of polyubiquitin- and LC3-binding regions of
p62/SQSTM1 following proteolytic cleavage [57]. The
loss of the polyubiquitin-binding region of p62/SQSTM1
may also disrupt proteasomal degradation of tau, as p62/
SQSTM1 participates in the shuttling of ubiquitinated tau
to the proteasome [102]. It has been hypothesized that im-
paired proteasomal degradation of soluble tau could lead
to its toxic accumulation [103,104], thus impairment in
the ubiquitin-proteasome system in P301S tau mice is also
conceivable. Therefore, our observations are consistent
with previous observations that disruptions in protein
degradation systems may occur in neurodegenerative
tauopathy [105], which is in line with previous reports of
autophagy disruption in other neurodegenerative diseases
[106-109].
Since exercise is known to produce a variety of positive
changes in the CNS, we cannot exclude the possibility that
other mechanisms may underlie the reductions in tau
pathology we observed. Several types of exercise are
known to increase the level of neurotrophins in the CNS,
particularly, brain-derived neurotrophic factor (BDNF)
[110-114], which increases neuronal survival and differen-
tiation [115]. Elevated levels of BDNF also decrease tau
phosphorylation via the PI3K-Akt pathway by decreasing
the activity of glycogen synthase kinase-3β (GSK-3β), a
major tau kinase [116,117]. In the present study it is pos-
sible that exercise-induced increase in BDNF levels (and
decreased GSK-3β activity) resulted in the attenuation tau
phosphorylation we observed. Indeed, recent evidence
suggests that forced treadmill exercise elevates the levels
of inactivated phospho-GSK-3β in the brain [74,118]. This
evidence supports an alternate mechanism by which exer-
cise can modulate the progression of tau pathology, which
warrants further investigation in future studies with P301S
mice.
In conclusion, our work demonstrates that 12 weeks of
forced treadmill exercise significantly attenuates tau path-
ology in the spinal cord and has moderate effects in the
brains of older P301S tau mice, but that treadmill exercise
does not prevent the progressive underlying neurodegen-
eration associated with tauopathy when introduced at
later ages. Given that our results show exercise modulates
tauopathy, our observations suggest that there may be a
critical window whereby exercise can have the greatest
impact on disease progression; the introduction of forced
treadmill exercise before the development of severepathology may be more beneficial. Our results also sup-
port the possibility for a role of autophagy in the exercise-
induced reduction of tauopathy, and that autophagy and/
or proteasomal dysfunction in P301S tau mice may con-
tribute to the development of tau pathology.
Materials and methods
Animals
The P301S tau transgenic mouse expresses human tau
(1N4R) with a P301S mutation [52]. These mice display
progressive neurofibrillary tangle (NFT) pathology and
neurodegeneration in the brain and spinal cord, develop-
ing lower-limb weakness around 6 months of age. P301S
tau mice (7–8 months old), and their age-matched non-
transgenic controls were individually housed in the animal
facility at the University of Houston. Mice were housed in
a climate-controlled room (25°C) on a 12/12 h light/
dark cycle and given food and water ad libitum. All ex-
periments were approved by the University of Houston
Institutional Animal Care and Use Committee and im-
plemented following the National Research Council’s
Guide of The Care and Use of Laboratory Animals.
Forced treadmill exercise
Mice were designated to four groups: exercised (Tg-EX)
and sedentary (Tg-SED) P301S mice along with their
non-transgenic exercised (NTg-EX) and sedentary (NTg-
SED) counterparts. Beginning at 7 months of age, mice
ran on a six-lane motorized treadmill (Columbus Instru-
ments, Columbus, OH, USA) 5 days/week for 40 min/day
for 12 weeks. The mice in the exercise groups were
trained on treadmill running with a speed up to 15 m/min
(5 min at 6 m/min, 5 min at 9 m/min, 20 min at 12 m/
min, 5 min at 15 m/min, and 5 min at 12 m/min) with a
0° inclination. All exercised mice ran 450 m per day with a
total of 27 km for the 12 week duration of the study. This
exercise protocol has been shown to produce cardiorespi-
ratory and metabolic adaptations similar to those seen in
humans while exercising [53,54,119]. The sedentary mice
were brought to the exercise facility in order to expose
these mice to the same conditions as the exercised mice.
In order to ensure that all mice were able to complete
the exercise protocol, mice were qualitatively evaluated
throughout the duration of exercise trials.
Open field activity
Mice were tested 48 h after completion of 12 weeks of en-
durance treadmill exercise. Mice were placed in the center
of a 60 × 40 cm Plexiglas box and allowed to explore the
area for 30 min. Open field activity was measured in
standard lighting conditions using a computer-operated
Opto-Varimex Micro Activity Meter v2.00 system, as pre-
viously described [120]. Briefly, each Plexiglas testing
chamber contained sensors with 8-infared light emitting
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light beams. Movement was detected by beam breaks, and
the Opto-Varimex program recorded total activity counts,
distance traveled, ambulatory activity counts, rearing ac-
tivity counts and stereotypic activity counts.Tissue extraction
Mice were sacrificed under carbon dioxide (CO2) anesthe-
sia and the brains and spinal cords were dissected. Each
hemibrain and spinal cord was placed in Accustain (a pro-
prietary formalin-free fixative from Sigma-Aldrich, St.
Louis, MO, USA) for tissue fixation for 24 hours at 4°C.
After Accustain fixation, the hemibrain and spinal cord
were stored in 70% ethanol at 4°C for paraffin processing.
The other half of each brain and the cervical spinal cord
were snap frozen stored at −80°C for biochemical process-
ing. Tissues were homogenized in cold RIPA lysis and ex-
traction buffer (Thermo-Fisher Scientific, Rockford, IL,
USA) containing protease and phosphatase inhibitors.
Samples were then centrifuged at 20,000 × g for 20 min at
4°C. The pellet was discarded, and a portion of the
RIPA lysate was used for biochemical analysis. Sarkosyl-
insoluble tau was isolated following previous reports [55],
with RIPA supernatants adjusted to 1% sarkosyl. Samples
were incubated for 1 hr at room temperature and then
spun at 100,000 × g at room temperature. The superna-
tants were discarded and the pellets were resuspended in
O+ buffer (62.5 mM Tris–HCl, 10% glycerol, 5% 2-
mercaptoethanol, 0.1% SDS, phosphatase and protease
inhibitors). Samples were then boiled for 3 min and
kept at −20°C for Western blot analysis.Immunofluorescence and image analysis
Brain and lumbar spinal cord tissue was paraffin proc-
essed and sectioned at a 10 μm thickness. Immunofluores-
cence was performed on the lumbar spinal cord and
hemibrain sections using the TAU5 antibody (anti-TAU,
1:500, Invitrogen) that recognizes phosphorylated and
non-phosphorylated tau and phospho-dependent anti-
bodies: AT8 (anti-pSer202/Thr205, 1:500, Thermo Sci-
entific), AT100 (anti-pSer212/Thr214, 1:500, Thermo
Scientific), and AT180 (anti-pThr231, 1:500, Thermo
Scientific). Additionally, double immunofluorescence
with a subset of P301S mice (n = 4 mice per group)
with TAU5 (1:500) and the T22 antibody (1:200, kindly
donated by Dr. R. Kayed), which specifically recognizes
oligomeric forms of tau [121]. For image analysis, up to
six equidistant sections were chosen per animal, corre-
sponding to plates 42 to 49 in the brain [122] and L1 to
L6 of the spinal cord [123]. Integrated density analysis
was measured by a blinded observer with NIH Image J
software to quantify total immunofluorescence staining
per relevant area (spinal cord, cortex, or hippocampus)for each section, using a method by Barbero-Camps
and colleagues to quantify immunofluorescence [124].
Immunohistochemistry and image analysis
Brain and lumbar spinal cord tissue was paraffin proc-
essed and sectioned at a 10 μm thickness and the same
brain plate and spinal cord regions used in the immuno-
fluorescence analysis were used. Immunohistochemistry
was performed on equidistant sections from the lumbar
spinal cord (n ≥ 4 sections per animal) and hemibrain
(n ≥ 4 sections per animal) using anti-NeuN (1:1000,
Millipore). Sections were incubated in primary antibody
overnight at 4°C, incubated with horseradish peroxidase-
labeled secondary antibody and stained with DAB. The
number of positively-stained neurons with a clearly iden-
tifiable nucleus were quantified by a blinded observer
using NIH Image J software to determine the number of
alpha motor neurons in the ventral horn of the spinal
cord as well as neurons in the cortex. For the hippocam-
pus, a 200 μm × 1000 μm rectangular region of the CA3
and CA1 was quantified manually [52].
Western blot and dot blot analysis
Spinal cord, hippocampus, and cortex samples from both
RIPA and sarkosyl extractions were resolved by SDS-
PAGE or dot blot. Blots were probed with tau antibodies
[TAU5, (1:1000), AT8 (1:1000), AT100 (1:1000) and
AT180 (1:250)], and autophagy-related antibodies (anti-
LC3, 1:500, Novus Biologicals; anti-p62, 1:1000, BD
Biosciences). After overnight incubation at 4°C, blots
were incubated in horseradish peroxidase-labeled second-
ary antibodies and visualized with an ECL substrate kit
(Amersham). Band densities were analyzed with NIH
Image J software and band values were normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Dot blots were prepared by pipetting 1.2 ul of each
sample in each square of a nitrocellulose membrane and
allowed to dry for 30 minutes. Blots were incubated with
T22 (1:250), overnight at 4°C followed by incubation
with a horseradish peroxidase-labeled secondary and
visualization with ECL. Dot intensities were analyzed
with NIH Image J software.
Statistical analysis
A Student’s t-test was used to compare exercised and sed-
entary P301S mice. A two-way ANOVA was used to
compare all four groups (Tg-EX, Tg-SED, NTg-EX, and
NTg-SED). After the ANOVA, a Newman-Keuls post-hoc
(for behavioral tests; [125]) or Tukey’s HSD post-hoc was
used to compare the significant effects between groups.
All results are displayed as mean ± SEM.
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